Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Scytalone dehydratase is an enzyme (EC 4.2.1.94) in the lyase family, specifically classified as a hydro-lyase, that catalyzes the dehydration of scytalone to 1,3,8-trihydroxynaphthalene as a critical step in the biosynthesis of dihydroxynaphthalene (DHN) melanin in fungi[2][9]. This enzyme is essential for the pathogenicity of certain phytopathogenic fungi, most notably *Magnaporthe grisea* (now *Pyricularia oryzae*), which causes rice blast disease—a major threat to rice cultivation[5][6][9]. Scytalone dehydratase is a trimeric protein, with each subunit comprising about 129 amino acids and adopting a cone-shaped alpha + beta barrel that encloses a hydrophobic active site[1][6]. It serves as a validated molecular target for antifungal drug design, with inhibitors such as carpropamid directly binding to and blocking the enzyme, resulting in inhibition of fungal melanin synthesis and reduced virulence[4][5][7]. The catalytic mechanism involves keto-enol tautomerization and syn elimination of water in an E1cb-like manner, with key residues (e.g., Asp-31, His-85) facilitating proton abstraction and stabilization of intermediates[3][9]. Structure-based inhibitor discovery exploiting the unique active site geometry has yielded potent synthetic fungicides[7].
Competitive inhibition of the active site (for carpropamid and other inhibitors), Displacement of active-site water (for certain synthetic inhibitors), Inhibition of melanin pathway decreases fungal pathogenicity
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Scytalone dehydratase (SD).